Cover Image
Market Research Report

Acne Vulgaris - Epidemiology Forecast to 2026

Published by GlobalData Product code 622443
Published Content info 37 Pages
Delivery time: 1-2 business days
Price
Back to Top
Acne Vulgaris - Epidemiology Forecast to 2026
Published: March 1, 2018 Content info: 37 Pages
Description

Acne vulgaris (acne) is a chronic inflammatory skin disease that presents as open or closed comedones and inflammatory lesions. Comedones include blackheads and whiteheads, while inflammatory lesions include papules, pustules, or cysts. Acne is a common skin disease that predominantly affects adolescents and young adults, but can also persist into adulthood. Mortality is not associated with acne, although major physical and psychological characteristics may develop, such as acne scarring, poor self-esteem, depression, and anxiety. The distribution of acne in the population is influenced by genetic background and dietary habits.

In the 7MM, epidemiologists forecast that the total prevalent cases of acne vulgaris will decrease by an Annual Growth Rate (AGR) of negative 0.13% per year over the next 10 years, to about 155.9 million cases in 2026. In the 7MM, the US had the highest number of total prevalent cases with over 64 million cases in 2016, while Spain had the lowest number of total prevalent cases in 2016. In the 7MM, the 18-60 year age group had the highest number of total prevalent cases of acne vulgaris, contributing approximately three-quarters of cases to the total in 2016. In the combined 7MM in 2016, total prevalent cases of acne vulgaris were higher in women compared with men, with around 93.6 million (approximately 60%) cases occurring in women and approximately 40% cases occurring in men.

The report "Acne Vulgaris - Epidemiology Forecast to 2026", provides an overview of the risk factors and global trends for acne vulgaris in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for total and diagnosed prevalent cases of acne vulgaris segmented by sex and age (7-9 years, 10-17 years, and 18-60 years). Diagnosed prevalent cases of acne vulgaris are further segmented by severity (mild, moderate, severe) in both children and adolescents (7-17 years) and adults (18-60 years).

Scope

  • The Acne Vulgaris report provides an overview of the risk factors and global trends for acne vulgaris in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
  • It includes a 10-year epidemiological forecast for total and diagnosed prevalent cases of acne vulgaris segmented by sex and age (7-9 years, 10-17 years, and 18-60 years). Diagnosed prevalent cases of acne vulgaris are further segmented by severity (mild, moderate, severe) in both children and adolescents (7-17 years) and adults (18-60 years).
  • The acne vulgaris epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
  • The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

The Acne Vulgaris Epidemiology report will allow you to -

  • Develop business strategies by understanding the trends shaping and driving the global acne vulgaris market.
  • Quantify patient populations in the global acne vulgaris market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for acne vulgaris therapeutics in each of the markets covered.
  • Understand magnitude of acne vulgaris population by disease severity.
Table of Contents
Product Code: GDHCER179-18

Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 3
  • 1.2 List of Figures 3

2 Acne Vulgaris: Executive Summary 4

  • 2.1 Related Reports 6
  • 2.2 Upcoming Reports 7

3 Epidemiology 8

  • 3.1 Disease Background 8
  • 3.2 Risk Factors and Comorbidities 8
  • 3.3 Global and Historical Trends 9
    • 3.3.1 US 11
    • 3.3.2 5EU 11
    • 3.3.3 Japan 12
  • 3.4 Forecast Methodology 13
    • 3.4.1 Sources 13
    • 3.4.2 Forecast Assumptions and Methods 16
  • 3.5 Epidemiological Forecast for Acne Vulgaris (2016-2026) 21
    • 3.5.1 Total Prevalent Cases of Acne Vulgaris 21
    • 3.5.2 Diagnosed Prevalent Cases of Acne Vulgaris 22
    • 3.5.3 Age-Specific Diagnosed Prevalent Cases of Acne Vulgaris 23
    • 3.5.4 Sex-Specific Diagnosed Prevalent Cases of Acne Vulgaris 24
    • 3.5.5 Diagnosed Prevalent Cases of Acne Vulgaris by Severity 25
  • 3.6 Discussion 27
    • 3.6.1 Epidemiological Forecast Insight 27
    • 3.6.2 Limitations of Analysis 27
    • 3.6.3 Strengths of Analysis 28

4 Appendix 29

  • 4.1 Bibliography 29
  • 4.2 Primary Research - KOLs Interviewed for this Report 31
  • 4.3 Primary Research - Prescriber Survey 33
  • 4.4 About the Authors 34
    • 4.4.1 Epidemiologist 34
    • 4.4.2 Reviewers 34
    • 4.4.3 Global Director of Therapy Analysis and Epidemiology 35
    • 4.4.4 Global Head and EVP of Healthcare Operations and Strategy 36
  • 4.5 About GlobalData 37
  • 4.6 Contact Us 37
  • 4.7 Disclaimer 37

List of Tables

  • Table 1: Risk Factors and Comorbidities for Diagnosed Prevalent Cases of Acne Vulgaris 9
  • Table 2: 7MM, Total Prevalent Cases of Acne Vulgaris, Ages 7-60 Years, Both Sexes, N, Select Years 2016-2026 22
  • Table 3: 7MM, Diagnosed Prevalent Cases of Acne Vulgaris, Ages 7-60 Years, Both Sexes, N, Select Years 2016-2026 23
  • Table 4: High-Prescribing Physicians (non-KOLs) Surveyed, By Country 34

List of Figures

  • Figure 1: 7MM, Total Prevalent Cases of Acne Vulgaris, Both Sexes, Ages 7-60 Years, 2016 and 2026 5
  • Figure 2: 7MM, Diagnosed Prevalent Cases of Acne Vulgaris, Both Sexes, Ages 7-60 Years, 2016 and 2026 6
  • Figure 3: Age-Standardized Total Prevalence of Acne Vulgaris, Ages 7-60 Years, 2016 10
  • Figure 4: Age-Standardized Diagnosed Prevalence of Acne Vulgaris, Ages 7-60 Years, 2016 11
  • Figure 5: Sources Used and Not Used to Forecast Total Prevalent Cases of Acne Vulgaris 14
  • Figure 6: Sources Used to Forecast Diagnosed Prevalent Cases of Acne Vulgaris 15
  • Figure 7: Sources Used and Not Used to Forecast Diagnosed Prevalent Cases of Acne Vulgaris by Severity 16
  • Figure 8: 7MM, Age-Specific Diagnosed Prevalent Cases of Acne Vulgaris, Both Sexes, 2016 24
  • Figure 9: 7MM, Sex-Specific Diagnosed Prevalent Cases of Acne Vulgaris, Ages 7-60 Years, 2016 25
  • Figure 10: 7MM, Diagnosed Prevalent Cases of Acne Vulgaris, Ages 7-17 Years, Both Sexes, N, 2016 26
  • Figure 11: 7MM, Diagnosed Prevalent Cases of Acne Vulgaris, Ages 18-60 Years, Both Sexes, 2016 26
Back to Top